Kriya Therapeutics
Morrisville, US · Founded 2019 · Delaware corporation · 5 known investors
Founders & leadership
NV
Neelaksh VarshneyDirector
MS
Michele StoneExecutive Officer
IO
Ilan OrenDirector
SR
Saira RamasastryDirector
RG
Ryan GallagherDirector
KM
Keith ManchesterDirector
KE
Katherine EadeExecutive Officer
JM
James MomtazeeDirector
AR
Akshay RaiDirector
SR
Shankar RamaswamyExecutive Officer, Director
CH
Curt HerbertsExecutive Officer
BP
Britt PettyExecutive Officer
Investors · 5
Reported raises · per SEC filings
Form D private placements▶$320.8MraisedSep 2025 · 10 investors · BiotechnologyRule 506(b)
▶$320.8MraisedSep 2025 · 10 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Neelaksh VarshneyDirector
- Michele StoneExecutive Officer
- Ilan OrenDirector
- Saira RamasastryDirector
- Ryan GallagherDirector
- Keith ManchesterDirector
- Katherine EadeExecutive Officer
- James MomtazeeDirector
- Akshay RaiDirector
- Shankar RamaswamyExecutive Officer, Director
- Curt HerbertsExecutive Officer
- Britt PettyExecutive Officer
- Roger JeffsDirector
- Brian FurmanskiExecutive Officer
- Trit GargDirector
- Offering amount
- $320.8M
- Amount sold
- $320.8M
- First sale
- Jul 2025
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$361.8MraisedJul 2023 · 29 investors · BiotechnologyRule 506(b)
▶$361.8MraisedJul 2023 · 29 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- James MomtazeeDirector
- Neelaksh VarshneyDirector
- Roger JeffsDirector
- Dana JohnsonExecutive Officer
- Britt PettyExecutive Officer
- Trit GargDirector
- Michele StoneExecutive Officer
- Curt HerbertsExecutive Officer
- Keith ManchesterDirector
- Saira RamasastryDirector
- Shankar RamaswamyExecutive Officer, Director
- Ilan OrenDirector
- Offering amount
- $432M
- Amount sold
- $361.8M
- First sale
- May 2022
- Incorporated
- Corporation, Delaware, 2019
- Federal exemptions
- 06b
▶$100MraisedJul 2021 · 36 investors · BiotechnologyRule 506(b)
▶$100MraisedJul 2021 · 36 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Daniel ChenExecutive Officer
- Ilan OrenDirector
- Keith ManchesterDirector
- Saira RamasastryDirector
- Roger JeffsDirector
- C.R. SincockDirector
- Dana JohnsonExecutive Officer
- James MomtazeeDirector
- Shankar RamaswamyExecutive Officer, Director
- Offering amount
- $100M
- Amount sold
- $100M
- First sale
- Jun 2021
- Incorporated
- Corporation, Delaware, 2019
- Federal exemptions
- 06b
▶$87.6MraisedAug 2020 · 21 investors · BiotechnologyRule 506(b)
▶$87.6MraisedAug 2020 · 21 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Ilan OrenDirector
- Keith ManchesterDirector
- Roger JeffsDirector
- C.R. SincockDirector
- Shankar RamaswamyExecutive Officer, Director
- Offering amount
- $87.6M
- Amount sold
- $87.6M
- First sale
- May 2020
- Incorporated
- Corporation, Delaware, 2019
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.